Insulet Corp. (NSDQ:PODD) announced today that it acquired Neighborhood Diabetes Inc. for $63 million in cash and stock, a move that more than triples Insulet’s customer base.
With the acquisition of its fellow Bay State firm, Bedford, Mass.-based Insulet offers its customers a suite of diabetes management products including glucose testing supplies, continuous glucose monitoring sensors and insulin to go with its flagship Omnipod insulin management system.